USP22 activates multiple EGFR downstream signaling pathways, including the STAT3, AKT/mTOR, and MEK/ERK pathways, in lung ADC (adenocarcinoma) cell lines H1975 and PC9, and it stabilizes EGFR protein expression [60]. This evidence concerns the gene EGFR and adenocarcinoma.